The electronic Contract Proposal Submission (eCPS) is a component of NIH’s integrated, secure system for the electronic submission, capture, tracking and review of contract proposals.
WARNING NOTICE: This is a U.S. Government computer system, which may be accessed and used only for authorized Government business by authorized personnel. Unauthorized access or use of this computer system may subject violators to criminal, civil, and/or administrative action.
All information on this computer system may be intercepted, recorded, read, copied, and disclosed by and to authorized personnel for official purposes, including criminal investigations. Such information includes sensitive data encrypted to comply with confidentiality and privacy requirements. Access or use of this computer system by any person, whether authorized or unauthorized, constitutes consent to these terms. There is no right of privacy in this system.
The following table represents NIH/SAMHSA contract solicitations that are available for electronic proposal submission through eCPS. Please Note: Proposals will not be accepted through eCPS after the closing date and time. Potential offerors are instructed to go to FedBizOpps.gov for the full listing of active contract opportunities.
|ICID||FedBizOpps.gov Solicitation Link||Solicitation Type||Title||Contract Specialist||Closing Date and Time [ET]||Agency||Sort order|
|NIAID||NIAID-DAIDS-NIHAI201800011||Solicitation||Simian Vaccine Evaluation Units (SVEUs)||Virts, Ashley||4/25/2019 03:00 PM||NIH/NIAID||0|
|NLM||75N97019Q00042MS||Sources Sought||HSDB:1) Primary Record Building: Substance Identification, Safety and Handling, Toxicity/Biomedical effects, Pharmacology, Exposure Standards and Regulations, Monitoring and Analysis Methods, and Additional References, and 2) Review Panel Support||Simmonds, Markita||4/26/2019 12:00 PM||NIH/NLM||0|
|NIDA||75N9502019R00003||Solicitation||Analytical Chemistry and Stability Testing of Treatment Drugs for Substance Use Disorders||Simon, Renu||4/26/2019 03:00 PM||NIH/NIDA||0|
|NCI||75N91019R00016||Solicitation||Protocol Participant Support||Katzper, Margo||5/08/2019 12:00 PM||NIH/NCI||0|
|NIDA||NIH-NINDS-75N95019R00027||Combined Synopsis/Solicitation||Screening of Investigational Agents through the "NINDS Preclinical Screening Platform for Pain" (PSPP)||Plugge, Rieka||5/10/2019 05:00 PM||NIH/NIDA||0|
|NIAID||75N93019R00006||Solicitation||NIAID Evaluation Services||Lear, Matt||5/13/2019 03:00 PM||NIH/NIAID||0|
|NIAID||NIAID-DAIDS-NIHAI201800016||Solicitation||NIAID CLINICAL RESEARCH PRODUCTS MANAGEMENT CENTER||Patel, Kishan||5/15/2019 03:00 PM||NIH/NIAID||0|
|NIDA||75N95019R00046||Solicitation||Clinical Services and Resources for the National Institute on Drug Abuse||Klimenkova, Polina||5/20/2019 12:00 PM||NIH/NIDA||0|
|NIAID||HHS-NIH-NIAID-BAA2019-1||Solicitation||RESEARCH AREA 001 - Development of Radiation/Nuclear Medical Countermeasures (MCMs)||Nguyen, Liem||5/20/2019 03:00 PM||NIH/NIAID||0|
|NIAID||HHS-NIH-NIAID-BAA2019-1||Solicitation||RESEARCH AREA 002 - Development of Therapeutic Products for Antibiotic Resistant Bacteria||Kennedy, GEORGE||5/20/2019 03:00 PM||NIH/NIAID||0|
|NIAID||HHS-NIH-NIAID-BAA2019-1||Solicitation||RESEARCH AREA 003 - Advanced Development of Vaccine Candidates for Antibiotic Resistant Bacteria||Kennedy, GEORGE||5/20/2019 03:00 PM||NIH/NIAID||0|
|NIDA||75N95019R0040||Solicitation||Preparation and Distribution of Research Drug Products||Bielen, Lisa||5/24/2019 03:00 PM||NIH/NIDA||0|
|NIAID||NIAID-NIH-RFP-NIHAI201800020||Solicitation||RNCP-WIDE DOSIMETRY GUIDANCE & MONITORING OF SOURCES AND IRRADIATION PROTOCOLS (CLINICAL TRIAL NOT ALLOWED)||Bannister, Emily||7/19/2019 03:00 PM||NIH/NIAID||0|
|NIAID||BAA-DAIT-75N93019R00009||Solicitation||Development of Vaccines for the Treatment of Opioid Use Disorder||Ralis, George||9/18/2019 03:00 PM||NIH/NIAID||0|